AST 0 3 0 3 B-clinical_variable
and 4 7 4 7 I-clinical_variable
ALT 8 11 8 11 I-clinical_variable
≤ 12 13 12 13 O
3 14 15 14 15 B-upper_bound
x 16 17 16 17 I-upper_bound
ULN 18 21 18 21 I-upper_bound

Active 0 6 22 28 O
brain 7 12 29 34 B-cancer
metastases 13 23 35 45 I-cancer
or 24 26 46 48 O
leptomeningeal 27 41 49 63 B-cancer
metastases 42 52 64 74 I-cancer

Age 0 3 75 78 B-age
≥ 4 5 79 80 O
18 6 8 81 83 B-lower_bound
years 9 14 84 89 I-lower_bound

Albumin 0 7 90 97 B-clinical_variable
≥ 8 9 98 99 O
3.0 10 13 100 103 B-lower_bound
g 14 15 104 105 I-lower_bound
/ 15 16 105 106 I-lower_bound
dL 16 18 106 108 I-lower_bound

All 0 3 109 112 O
baseline 4 12 113 121 O
laboratory 13 23 122 132 O
requirements 24 36 133 145 O
will 37 41 146 150 O
be 42 44 151 153 O
assessed 45 53 154 162 O
and 54 57 163 166 O
should 58 64 167 173 O
be 65 67 174 176 O
obtained 68 76 177 185 O
within 77 83 186 192 O
14 84 86 193 195 B-upper_bound
days 87 91 196 200 I-upper_bound
of 92 94 201 203 O
the 95 98 204 207 O
first 99 104 208 213 O
dose 105 109 214 218 O
of 110 112 219 221 O
study 113 118 222 227 B-treatment
drug 119 123 228 232 I-treatment

All 0 3 233 236 O
toxicities 4 14 237 247 O
attributed 15 25 248 258 O
to 26 28 259 261 O
prior 29 34 262 267 B-treatment
anti 35 39 268 272 I-treatment
- 39 40 272 273 I-treatment
cancer 40 46 273 279 I-treatment
therapy 47 54 280 287 I-treatment
other 55 60 288 293 O
than 61 65 294 298 O
alopecia 66 74 299 307 B-chronic_disease
and 75 78 308 311 O
fatigue 79 86 312 319 O
must 87 91 320 324 O
have 92 96 325 329 O
resolved 97 105 330 338 O
to 106 108 339 341 O
grade 109 114 342 347 B-lower_bound
1 115 116 348 349 I-lower_bound
( 117 118 350 351 O
CTCAE 118 123 351 356 B-clinical_variable
version 124 131 357 364 I-clinical_variable
4 132 133 365 366 I-clinical_variable
) 133 134 366 367 O
or 135 137 368 370 O
baseline 138 146 371 379 O
before 147 153 380 386 O
administration 154 168 387 401 O
of 169 171 402 404 O
study 172 177 405 410 O
drug 178 182 411 415 O

Any 0 3 416 419 O
serious 4 11 420 427 O
or 12 14 428 430 O
uncontrolled 15 27 431 443 O
medical 28 35 444 451 B-chronic_disease
disorder 36 44 452 460 I-chronic_disease
that 45 49 461 465 O
, 49 50 465 466 O
in 51 53 467 469 O
the 54 57 470 473 O
opinion 58 65 474 481 O
of 66 68 482 484 O
the 69 72 485 488 O
investigator 73 85 489 501 O
, 85 86 501 502 O
may 87 90 503 506 O
increase 91 99 507 515 O
the 100 103 516 519 O
risk 104 108 520 524 O
associated 109 119 525 535 O
with 120 124 536 540 O
study 125 130 541 546 O
participation 131 144 547 560 O
or 145 147 561 563 O
study 148 153 564 569 B-treatment
drug 154 158 570 574 I-treatment
administration 159 173 575 589 O
, 173 174 589 590 O
impair 175 181 591 597 O
the 182 185 598 601 O
ability 186 193 602 609 O
of 194 196 610 612 O
the 197 200 613 616 O
subject 201 208 617 624 O
to 209 211 625 627 O
receive 212 219 628 635 O
protocol 220 228 636 644 O
therapy 229 236 645 652 B-treatment
or 237 239 653 655 O
interfere 240 249 656 665 O
with 250 254 666 670 O
the 255 258 671 674 O
interpretation 259 273 675 689 O
of 274 276 690 692 O
study 277 282 693 698 O
results 283 290 699 706 O

At 0 2 707 709 O
the 3 6 710 713 O
time 7 11 714 718 O
of 12 14 719 721 O
day 15 18 722 725 O
1 19 20 726 727 O
of 21 23 728 730 O
the 24 27 731 734 O
study 28 33 735 740 O
, 33 34 740 741 O
patients 35 43 742 750 O
must 44 48 751 755 O
have 49 53 756 760 O
completed 54 63 761 770 O
chemotherapy 64 76 771 783 B-treatment
, 76 77 783 784 O
targeted 78 86 785 793 B-treatment
therapy 87 94 794 801 I-treatment
, 94 95 801 802 O
investigational 96 111 803 818 B-treatment
therapy 112 119 819 826 I-treatment
, 119 120 826 827 O
other 121 126 828 833 O
immunotherapy 127 140 834 847 B-treatment
, 140 141 847 848 O
radiation 142 151 849 858 B-treatment
therapy 152 159 859 866 I-treatment
or 160 162 867 869 O
major 163 168 870 875 B-treatment
surgery 169 176 876 883 I-treatment
( 177 178 884 885 O
requiring 178 187 885 894 O
general 188 195 895 902 B-treatment
anesthesia 196 206 903 913 I-treatment
) 206 207 913 914 O
at 208 210 915 917 O
least 211 216 918 923 O
28 217 219 924 926 B-upper_bound
days 220 224 927 931 I-upper_bound
before 225 231 932 938 O
administration 232 246 939 953 O
of 247 249 954 956 O
the 250 253 957 960 O
first 254 259 961 966 O
dose 260 264 967 971 O
of 265 267 972 974 O
nivolumab 268 277 975 984 B-treatment

Bilirubin 0 9 985 994 B-clinical_variable
≤ 10 11 995 996 O
1.5 12 15 997 1000 B-upper_bound
x 16 17 1001 1002 I-upper_bound
ULN 18 21 1003 1006 I-upper_bound

Eastern 0 7 1007 1014 B-clinical_variable
Cooperative 8 19 1015 1026 I-clinical_variable
Oncology 20 28 1027 1035 I-clinical_variable
Group 29 34 1036 1041 I-clinical_variable
( 35 36 1042 1043 I-clinical_variable
ECOG 36 40 1043 1047 I-clinical_variable
) 40 41 1047 1048 I-clinical_variable
performance 42 53 1049 1060 I-clinical_variable
status 54 60 1061 1067 I-clinical_variable
of 61 63 1068 1070 O
0 64 65 1071 1072 B-lower_bound
- 65 66 1072 1073 O
1 66 67 1073 1074 B-upper_bound

Expected 0 8 1075 1083 O
survival 9 17 1084 1092 O
of 18 20 1093 1095 O
at 21 23 1096 1098 O
least 24 29 1099 1104 O
4 30 31 1105 1106 B-lower_bound
months 32 38 1107 1113 I-lower_bound

History 0 7 1114 1121 O
of 8 10 1122 1124 O
allergy 11 18 1125 1132 O
to 19 21 1133 1135 O
study 22 27 1136 1141 O
drug 28 32 1142 1146 O
component 33 42 1147 1156 O
or 43 45 1157 1159 O
history 46 53 1160 1167 O
of 54 56 1168 1170 O
severe 57 63 1171 1177 O
hypersensitivity 64 80 1178 1194 O
reaction 81 89 1195 1203 O
to 90 92 1204 1206 O
any 93 96 1207 1210 O
monoclonal 97 107 1211 1221 B-allergy_name
antibody 108 116 1222 1230 I-allergy_name

In 0 2 1231 1233 O
the 3 6 1234 1237 O
case 7 11 1238 1242 O
that 12 16 1243 1247 O
a 17 18 1248 1249 O
patient 19 26 1250 1257 O
had 27 30 1258 1261 O
a 31 32 1262 1263 O
tumor 33 38 1264 1269 B-cancer
sample 39 45 1270 1276 O
acquired 46 54 1277 1285 O
prior 55 60 1286 1291 O
to 61 63 1292 1294 O
consenting 64 74 1295 1305 O
to 75 77 1306 1308 O
the 78 81 1309 1312 O
study 82 87 1313 1318 O
and 88 91 1319 1322 O
this 92 96 1323 1327 O
tumor 97 102 1328 1333 O
sample 103 109 1334 1340 O
is 110 112 1341 1343 O
acceptable 113 123 1344 1354 O
for 124 127 1355 1358 O
processing 128 138 1359 1369 O
as 139 141 1370 1372 O
described 142 151 1373 1382 O
in 152 154 1383 1385 O
Appendix 155 163 1386 1394 O
4 164 165 1395 1396 O
( 166 167 1397 1398 O
i.e. 167 171 1398 1402 O
frozen 172 178 1403 1409 O
sample 179 185 1410 1416 O
stored 186 192 1417 1423 O
) 192 193 1423 1424 O
and 194 197 1425 1428 O
the 198 201 1429 1432 O
tumor 202 207 1433 1438 O
sample 208 214 1439 1445 O
was 215 218 1446 1449 O
acquired 219 227 1450 1458 O
within 228 234 1459 1465 O
60 235 237 1466 1468 B-upper_bound
days 238 242 1469 1473 I-upper_bound
of 243 245 1474 1476 O
starting 246 254 1477 1485 O
treatment 255 264 1486 1495 B-treatment
, 264 265 1495 1496 O
this 266 270 1497 1501 O
is 271 273 1502 1504 O
acceptable 274 284 1505 1515 O
and 285 288 1516 1519 O
a 289 290 1520 1521 O
new 291 294 1522 1525 O
biopsy 295 301 1526 1532 B-treatment
will 302 306 1533 1537 O
not 307 310 1538 1541 O
be 311 313 1542 1544 O
required 314 322 1545 1553 O

Inhaled 0 7 1554 1561 B-treatment
or 8 10 1562 1564 O
topical 11 18 1565 1572 B-treatment
steroids 19 27 1573 1581 I-treatment
, 27 28 1581 1582 O
and 29 32 1583 1586 O
adrenal 33 40 1587 1594 B-treatment
replacement 41 52 1595 1606 I-treatment
steroid 53 60 1607 1614 I-treatment
doses 61 66 1615 1620 O
are 67 70 1621 1624 O
permitted 71 80 1625 1634 O
in 81 83 1635 1637 O
the 84 87 1638 1641 O
absence 88 95 1642 1649 O
of 96 98 1650 1652 O
active 99 105 1653 1659 O
autoimmune 106 116 1660 1670 B-chronic_disease
disease 117 124 1671 1678 I-chronic_disease

Known 0 5 1679 1684 O
history 6 13 1685 1692 O
of 14 16 1693 1695 O
testing 17 24 1696 1703 O
positive 25 33 1704 1712 O
for 34 37 1713 1716 O
human 38 43 1717 1722 B-chronic_disease
immunodeficiency 44 60 1723 1739 I-chronic_disease
virus 61 66 1740 1745 I-chronic_disease
( 67 68 1746 1747 I-chronic_disease
HIV 68 71 1747 1750 I-chronic_disease
) 71 72 1750 1751 I-chronic_disease
or 73 75 1752 1754 O
known 76 81 1755 1760 O
acquired 82 90 1761 1769 B-chronic_disease
immunodeficiency 91 107 1770 1786 I-chronic_disease
syndrome 108 116 1787 1795 I-chronic_disease
( 117 118 1796 1797 I-chronic_disease
AIDS 118 122 1797 1801 I-chronic_disease
) 122 123 1801 1802 I-chronic_disease

Male 0 4 1803 1807 B-gender
subjects 5 13 1808 1816 I-gender
who 14 17 1817 1820 O
are 18 21 1821 1824 O
unwilling 22 31 1825 1834 B-contraception_consent
to 32 34 1835 1837 I-contraception_consent
use 35 38 1838 1841 I-contraception_consent
contraception 39 52 1842 1855 I-contraception_consent
during 53 59 1856 1862 O
the 60 63 1863 1866 O
treatment 64 73 1867 1876 B-treatment
and 74 77 1877 1880 O
for 78 81 1881 1884 O
at 82 84 1885 1887 O
least 85 90 1888 1893 O
31 91 93 1894 1896 B-lower_bound
weeks 94 99 1897 1902 I-lower_bound
after 100 105 1903 1908 I-lower_bound
the 106 109 1909 1912 O
last 110 114 1913 1917 O
dose 115 119 1918 1922 O
of 120 122 1923 1925 O
study 123 128 1926 1931 B-treatment
treatment 129 138 1932 1941 I-treatment
( 139 140 1942 1943 O
5 140 141 1943 1944 O
half 142 146 1945 1949 O
- 146 147 1949 1950 O
lives 147 152 1950 1955 O
of 153 155 1956 1958 O
study 156 161 1959 1964 B-treatment
drug 162 166 1965 1969 I-treatment
plus 167 171 1970 1974 O
90 172 174 1975 1977 B-upper_bound
days 175 179 1978 1982 I-upper_bound
duration 180 188 1983 1991 O
of 189 191 1992 1994 O
sperm 192 197 1995 2000 O
turnover 198 206 2001 2009 O
) 206 207 2009 2010 O

Must 0 4 2011 2015 O
be 5 7 2016 2018 O
at 8 10 2019 2021 O
least 11 16 2022 2027 O
28 17 19 2028 2030 B-lower_bound
days 20 24 2031 2035 I-lower_bound
since 25 30 2036 2041 O
craniotomy 31 41 2042 2052 B-treatment
and 42 45 2053 2056 O
resection 46 55 2057 2066 B-treatment
, 55 56 2066 2067 O
stereotactic 57 69 2068 2080 B-treatment
radiosurgery 70 82 2081 2093 I-treatment
, 82 83 2093 2094 O
or 84 86 2095 2097 O
whole 87 92 2098 2103 B-treatment
brain 93 98 2104 2109 I-treatment
radiotherapy 99 111 2110 2122 I-treatment

Must 0 4 2123 2127 O
have 5 9 2128 2132 O
no 10 12 2133 2135 O
evidence 13 21 2136 2144 O
of 22 24 2145 2147 O
progression 25 36 2148 2159 O
for 37 40 2160 2163 O
at 41 43 2164 2166 O
least 44 49 2167 2172 O
4 50 51 2173 2174 B-upper_bound
weeks 52 57 2175 2180 I-upper_bound
after 58 63 2181 2186 B-treatment
treatment 64 73 2187 2196 I-treatment
is 74 76 2197 2199 O
complete 77 85 2200 2208 O
and 86 89 2209 2212 O
within 90 96 2213 2219 O
28 97 99 2220 2222 B-upper_bound
days 100 104 2223 2227 I-upper_bound
prior 105 110 2228 2233 I-upper_bound
to 111 113 2234 2236 O
first 114 119 2237 2242 O
dose 120 124 2243 2247 O
of 125 127 2248 2250 O
study 128 133 2251 2256 O
drug 134 138 2257 2261 O
administration 139 153 2262 2276 O

Must 0 4 2277 2281 O
have 5 9 2282 2286 O
no 10 12 2287 2289 O
requirement 13 24 2290 2301 O
for 25 28 2302 2305 O
immunosuppressive 29 46 2306 2323 O
doses 47 52 2324 2329 O
of 53 55 2330 2332 O
systemic 56 64 2333 2341 B-treatment
corticosteroids 65 80 2342 2357 I-treatment
( 81 82 2358 2359 O
> 82 83 2359 2360 O
10 84 86 2361 2363 B-lower_bound
mg 87 89 2364 2366 I-lower_bound
/ 89 90 2366 2367 I-lower_bound
day 90 93 2367 2370 I-lower_bound
prednisone 94 104 2371 2381 B-treatment
equivalents 105 116 2382 2393 O
) 116 117 2393 2394 O
for 118 121 2395 2398 O
at 122 124 2399 2401 O
least 125 130 2402 2407 O
2 131 132 2408 2409 B-lower_bound
weeks 133 138 2410 2415 I-lower_bound
prior 139 144 2416 2421 I-lower_bound
to 145 147 2422 2424 O
study 148 153 2425 2430 B-treatment
drug 154 158 2431 2435 I-treatment
administration 159 173 2436 2450 O

Neutrophils 0 11 2451 2462 B-clinical_variable
≥ 12 13 2463 2464 O
1000 14 18 2465 2469 B-lower_bound
/ 18 19 2469 2470 I-lower_bound
μL 19 21 2470 2472 I-lower_bound

Other 0 5 2473 2478 O
prior 6 11 2479 2484 O
malignancy 12 22 2485 2495 B-cancer
active 23 29 2496 2502 O
within 30 36 2503 2509 O
the 37 40 2510 2513 O
previous 41 49 2514 2522 B-upper_bound
2 50 51 2523 2524 I-upper_bound
years 52 57 2525 2530 I-upper_bound
except 58 64 2531 2537 O
for 65 68 2538 2541 O
local 69 74 2542 2547 O
or 75 77 2548 2550 O
organ 78 83 2551 2556 O
confined 84 92 2557 2565 O
early 93 98 2566 2571 O
stage 99 104 2572 2577 O
cancer 105 111 2578 2584 B-cancer
that 112 116 2585 2589 O
has 117 120 2590 2593 O
been 121 125 2594 2598 O
definitively 126 138 2599 2611 O
treated 139 146 2612 2619 O
with 147 151 2620 2624 O
curative 152 160 2625 2633 B-treatment
intent 161 167 2634 2640 I-treatment
or 168 170 2641 2643 O
does 171 175 2644 2648 O
not 176 179 2649 2652 O
require 180 187 2653 2660 O
treatment 188 197 2661 2670 B-treatment
, 197 198 2670 2671 O
does 199 203 2672 2676 O
not 204 207 2677 2680 O
require 208 215 2681 2688 O
ongoing 216 223 2689 2696 O
treatment 224 233 2697 2706 O
, 233 234 2706 2707 O
has 235 238 2708 2711 O
no 239 241 2712 2714 O
evidence 242 250 2715 2723 O
of 251 253 2724 2726 O
active 254 260 2727 2733 O
disease 261 268 2734 2741 O
and 269 272 2742 2745 O
has 273 276 2746 2749 O
a 277 278 2750 2751 O
negligible 279 289 2752 2762 O
risk 290 294 2763 2767 O
of 295 297 2768 2770 O
recurrence 298 308 2771 2781 O
and 309 312 2782 2785 O
is 313 315 2786 2788 O
therefore 316 325 2789 2798 O
unlikely 326 334 2799 2807 O
to 335 337 2808 2810 O
interfere 338 347 2811 2820 O
with 348 352 2821 2825 O
the 353 356 2826 2829 O
endpoints 357 366 2830 2839 O
of 367 369 2840 2842 O
the 370 373 2843 2846 O
study 374 379 2847 2852 O

Palliative 0 10 2853 2863 B-treatment
( 11 12 2864 2865 I-treatment
limited 12 19 2865 2872 I-treatment
- 19 20 2872 2873 I-treatment
field 20 25 2873 2878 I-treatment
) 25 26 2878 2879 I-treatment
radiation 27 36 2880 2889 I-treatment
therapy 37 44 2890 2897 I-treatment
is 45 47 2898 2900 O
permitted 48 57 2901 2910 O
during 58 64 2911 2917 O
treatment 65 74 2918 2927 B-treatment
with 75 79 2928 2932 O
study 80 85 2933 2938 B-treatment
drug 86 90 2939 2943 I-treatment
( 91 92 2944 2945 I-treatment
s 92 93 2945 2946 I-treatment
) 93 94 2946 2947 I-treatment

Pathologically 0 14 2948 2962 O
confirmed 15 24 2963 2972 O
locally 25 32 2973 2980 O
advanced 33 41 2981 2989 O
or 42 44 2990 2992 O
metastatic 45 55 2993 3003 B-cancer
disease 56 63 3004 3011 I-cancer
per 64 67 3012 3015 O
the 68 71 3016 3019 O
treating 72 80 3020 3028 O
institution 81 92 3029 3040 O
's 92 94 3040 3042 O
standard 95 103 3043 3051 O
of 104 106 3052 3054 O
care 107 111 3055 3059 O
of 112 114 3060 3062 O
the 115 118 3063 3066 O
following 119 128 3067 3076 O
tumor 129 134 3077 3082 B-cancer
types 135 140 3083 3088 O

Patients 0 8 3089 3097 O
may 9 12 3098 3101 O
have 13 17 3102 3106 O
received 18 26 3107 3115 O
prior 27 32 3116 3121 B-treatment
focal 33 38 3122 3127 I-treatment
radiotherapy 39 51 3128 3140 I-treatment
for 52 55 3141 3144 O
palliation 56 66 3145 3155 O
of 67 69 3156 3158 O
an 70 72 3159 3161 O
isolated 73 81 3162 3170 O
site 82 86 3171 3175 O
of 87 89 3176 3178 O
disease 90 97 3179 3186 O
, 97 98 3186 3187 O
which 99 104 3188 3193 O
must 105 109 3194 3198 O
be 110 112 3199 3201 O
completed 113 122 3202 3211 O
at 123 125 3212 3214 O
least 126 131 3215 3220 O
14 132 134 3221 3223 B-lower_bound
days 135 139 3224 3228 I-lower_bound
prior 140 145 3229 3234 I-lower_bound
to 146 148 3235 3237 O
day 149 152 3238 3241 O
1 153 154 3242 3243 O
of 155 157 3244 3246 O
the 158 161 3247 3250 O
study 162 167 3251 3256 O

Platelets 0 9 3257 3266 B-clinical_variable
≥ 10 11 3267 3268 O
100 12 15 3269 3272 B-lower_bound
x 16 17 3273 3274 I-lower_bound
103 18 21 3275 3278 I-lower_bound
/ 21 22 3278 3279 I-lower_bound
μL 22 24 3279 3281 I-lower_bound

Positive 0 8 3282 3290 O
test 9 13 3291 3295 O
for 14 17 3296 3299 O
hepatitis 18 27 3300 3309 B-chronic_disease
B 28 29 3310 3311 I-chronic_disease
virus 30 35 3312 3317 I-chronic_disease
( 36 37 3318 3319 I-chronic_disease
HBV 37 40 3319 3322 I-chronic_disease
) 40 41 3322 3323 I-chronic_disease
using 42 47 3324 3329 O
HBV 48 51 3330 3333 O
surface 52 59 3334 3341 O
antigen 60 67 3342 3349 O
( 68 69 3350 3351 O
HBV 69 72 3351 3354 O
sAg 73 76 3355 3358 O
) 76 77 3358 3359 O
test 78 82 3360 3364 O
or 83 85 3365 3367 O
positive 86 94 3368 3376 O
test 95 99 3377 3381 O
for 100 103 3382 3385 O
hepatitis 104 113 3386 3395 B-chronic_disease
C 114 115 3396 3397 I-chronic_disease
virus 116 121 3398 3403 I-chronic_disease
( 122 123 3404 3405 I-chronic_disease
HCV 123 126 3405 3408 I-chronic_disease
) 126 127 3408 3409 I-chronic_disease
using 128 133 3410 3415 O
HCV 134 137 3416 3419 O
ribonucleic 138 149 3420 3431 O
acid 150 154 3432 3436 O
( 155 156 3437 3438 O
RNA 156 159 3438 3441 O
) 159 160 3441 3442 O
or 161 163 3443 3445 O
HCV 164 167 3446 3449 O
antibody 168 176 3450 3458 O
test 177 181 3459 3463 O
indicating 182 192 3464 3474 O
acute 193 198 3475 3480 B-chronic_disease
or 199 201 3481 3483 I-chronic_disease
chronic 202 209 3484 3491 I-chronic_disease
infection 210 219 3492 3501 I-chronic_disease

Prior 0 5 3502 3507 B-treatment
IL-2 6 10 3508 3512 I-treatment

Prior 0 5 3513 3518 B-treatment
therapy 6 13 3519 3526 I-treatment
with 14 18 3527 3531 I-treatment
BCG 19 22 3532 3535 I-treatment

Radiation 0 9 3536 3545 B-treatment
treatment 10 19 3546 3555 I-treatment
is 20 22 3556 3558 O
administered 23 35 3559 3571 O
12 36 38 3572 3574 B-lower_bound
weeks 39 44 3575 3580 I-lower_bound
or 45 47 3581 3583 O
greater 48 55 3584 3591 O
after 56 61 3592 3597 O
their 62 67 3598 3603 O
first 68 73 3604 3609 O
dose 74 78 3610 3614 O
of 79 81 3615 3617 O
study 82 87 3618 3623 B-treatment
drug 88 92 3624 3628 I-treatment

Radiographic 0 12 3629 3641 O
tumor 13 18 3642 3647 B-cancer
assessment 19 29 3648 3658 O
must 30 34 3659 3663 O
be 35 37 3664 3666 O
performed 38 47 3667 3676 O
within 48 54 3677 3683 O
28 55 57 3684 3686 B-upper_bound
days 58 62 3687 3691 I-upper_bound
prior 63 68 3692 3697 I-upper_bound
to 69 71 3698 3700 O
first 72 77 3701 3706 O
dose 78 82 3707 3711 O
of 83 85 3712 3714 O
study 86 91 3715 3720 B-treatment
drug 92 96 3721 3725 I-treatment

Serum 0 5 3726 3731 B-clinical_variable
creatinine 6 16 3732 3742 I-clinical_variable
≤ 17 18 3743 3744 O
1.5 19 22 3745 3748 B-upper_bound
x 23 24 3749 3750 I-upper_bound
ULN 25 28 3751 3754 I-upper_bound
( 29 30 3755 3756 O
or 30 32 3756 3758 O
glomerular 33 43 3759 3769 B-clinical_variable
filtration 44 54 3770 3780 I-clinical_variable
rate 55 59 3781 3785 I-clinical_variable
≥ 60 61 3786 3787 O
40mL 62 66 3788 3792 B-lower_bound
/ 66 67 3792 3793 I-lower_bound
min 67 70 3793 3796 I-lower_bound
) 70 71 3796 3797 O

Subjects 0 8 3798 3806 O
have 9 13 3807 3811 O
received 14 22 3812 3820 O
any 23 26 3821 3824 O
number 27 33 3825 3831 O
of 34 36 3832 3834 O
prior 37 42 3835 3840 B-treatment
lines 43 48 3841 3846 I-treatment
of 49 51 3847 3849 I-treatment
therapy 52 59 3850 3857 I-treatment
or 60 62 3858 3860 O
may 63 66 3861 3864 O
be 67 69 3865 3867 O
treatment 70 79 3868 3877 B-treatment
naïve 80 85 3878 3883 O

Subjects 0 8 3884 3892 O
may 9 12 3893 3896 O
have 13 17 3897 3901 O
received 18 26 3902 3910 O
any 27 30 3911 3914 O
number 31 37 3915 3921 O
of 38 40 3922 3924 O
prior 41 46 3925 3930 B-treatment
lines 47 52 3931 3936 I-treatment
of 53 55 3937 3939 I-treatment
therapy 56 63 3940 3947 I-treatment

Subjects 0 8 3948 3956 O
must 9 13 3957 3961 O
be 14 16 3962 3964 O
willing 17 24 3965 3972 O
and 25 28 3973 3976 O
able 29 33 3977 3981 O
to 34 36 3982 3984 O
comply 37 43 3985 3991 O
with 44 48 3992 3996 O
scheduled 49 58 3997 4006 O
visits 59 65 4007 4013 O
, 65 66 4013 4014 O
treatment 67 76 4015 4024 B-treatment
schedule 77 85 4025 4033 O
, 85 86 4033 4034 O
laboratory 87 97 4035 4045 O
tests 98 103 4046 4051 O
, 103 104 4051 4052 O
tumor 105 110 4053 4058 B-treatment
biopsies 111 119 4059 4067 O
, 119 120 4067 4068 O
and 121 124 4069 4072 O
other 125 130 4073 4078 O
requirements 131 143 4079 4091 O
of 144 146 4092 4094 O
the 147 150 4095 4098 O
stud 151 155 4099 4103 O

Subjects 0 8 4104 4112 O
must 9 13 4113 4117 O
consent 14 21 4118 4125 O
to 22 24 4126 4128 O
allow 25 30 4129 4134 O
for 31 34 4135 4138 O
the 35 38 4139 4142 O
acquisition 39 50 4143 4154 O
of 51 53 4155 4157 O
tumor 54 59 4158 4163 B-cancer
sample 60 66 4164 4170 O
prior 67 72 4171 4176 B-treatment
to 73 75 4177 4179 I-treatment
starting 76 84 4180 4188 I-treatment
treatment 85 94 4189 4198 I-treatment
on 95 97 4199 4201 O
study 98 103 4202 4207 O
( 104 105 4208 4209 O
in 105 107 4209 4211 O
most 108 112 4212 4216 O
cases 113 118 4217 4222 O
patients 119 127 4223 4231 O
will 128 132 4232 4236 O
require 133 140 4237 4244 O
a 141 142 4245 4246 O
tumor 143 148 4247 4252 B-treatment
biopsy 149 155 4253 4259 I-treatment
) 155 156 4259 4260 O

Subjects 0 8 4261 4269 O
must 9 13 4270 4274 O
have 14 18 4275 4279 O
disease 19 26 4280 4287 O
progression 27 38 4288 4299 O
or 39 41 4300 4302 O
refractory 42 52 4303 4313 O
disease 53 60 4314 4321 O
after 61 66 4322 4327 O
their 67 72 4328 4333 O
prior 73 78 4334 4339 B-treatment
line 79 83 4340 4344 I-treatment
of 84 86 4345 4347 I-treatment
therapy 87 94 4348 4355 I-treatment

Subjects 0 8 4356 4364 O
must 9 13 4365 4369 O
have 14 18 4370 4374 O
had 19 22 4375 4378 O
at 23 25 4379 4381 O
least 26 31 4382 4387 O
1 32 33 4388 4389 B-lower_bound
platinum 34 42 4390 4398 B-treatment
based 43 48 4399 4404 I-treatment
chemotherapy 49 61 4405 4417 I-treatment
regimen 62 69 4418 4425 I-treatment
for 70 73 4426 4429 O
the 74 77 4430 4433 O
treatment 78 87 4434 4443 B-treatment
of 88 90 4444 4446 O
metastatic 91 101 4447 4457 B-cancer
or 102 104 4458 4460 I-cancer
locally 105 112 4461 4468 I-cancer
advanced 113 121 4469 4477 I-cancer
unresectable 122 134 4478 4490 I-cancer
disease 135 142 4491 4498 I-cancer

Subjects 0 8 4499 4507 O
must 9 13 4508 4512 O
have 14 18 4513 4517 O
measurable 19 29 4518 4528 O
disease 30 37 4529 4536 O
by 38 40 4537 4539 O
CT 41 43 4540 4542 B-treatment
scans 44 49 4543 4548 O
or 50 52 4549 4551 O
MRI 53 56 4552 4555 B-treatment
per 57 60 4556 4559 O
RECIST 61 67 4560 4566 O
1.1 68 71 4567 4570 O
criteria 72 80 4571 4579 O

Subjects 0 8 4580 4588 O
who 9 12 4589 4592 O
are 13 16 4593 4596 O
compulsorily 17 29 4597 4609 O
detained 30 38 4610 4618 O
for 39 42 4619 4622 O
treatment 43 52 4623 4632 B-treatment
of 53 55 4633 4635 O
either 56 62 4636 4642 O
a 63 64 4643 4644 O
psychiatric 65 76 4645 4656 B-chronic_disease
or 77 79 4657 4659 O
physical 80 88 4660 4668 B-chronic_disease
( 89 90 4669 4670 O
e.g. 90 94 4670 4674 O
, 94 95 4674 4675 O
infectious 96 106 4676 4686 B-chronic_disease
disease 107 114 4687 4694 I-chronic_disease
) 114 115 4694 4695 O
illness 116 123 4696 4703 O

Subjects 0 8 4704 4712 O
who 9 12 4713 4716 O
have 13 17 4717 4721 O
received 18 26 4722 4730 O
prior 27 32 4731 4736 B-treatment
therapy 33 40 4737 4744 I-treatment
with 41 45 4745 4749 I-treatment
any 46 49 4750 4753 I-treatment
T 50 51 4754 4755 I-treatment
cell 52 56 4756 4760 I-treatment
co 57 59 4761 4763 I-treatment
- 59 60 4763 4764 I-treatment
stimulation 60 71 4764 4775 I-treatment
or 72 74 4776 4778 I-treatment
checkpoint 75 85 4779 4789 I-treatment
pathways 86 94 4790 4798 I-treatment
such 95 99 4799 4803 O
as 100 102 4804 4806 O
anti 103 107 4807 4811 B-treatment
- 107 108 4811 4812 I-treatment
PD-1 108 112 4812 4816 I-treatment
, 112 113 4816 4817 O
anti 114 118 4818 4822 B-treatment
- 118 119 4822 4823 I-treatment
PD 119 121 4823 4825 I-treatment
- 121 122 4825 4826 I-treatment
L1 122 124 4826 4828 I-treatment
, 124 125 4828 4829 O
anti 126 130 4830 4834 B-treatment
- 130 131 4834 4835 I-treatment
PD 131 133 4835 4837 I-treatment
- 133 134 4837 4838 I-treatment
L2 134 136 4838 4840 I-treatment
, 136 137 4840 4841 O
anti 138 142 4842 4846 B-treatment
- 142 143 4846 4847 I-treatment
CTLA-4 143 149 4847 4853 I-treatment
, 149 150 4853 4854 O
anti 151 155 4855 4859 B-treatment
- 155 156 4859 4860 I-treatment
CD137 156 161 4860 4865 I-treatment
; 161 162 4865 4866 O
or 163 165 4867 4869 O
other 166 171 4870 4875 O
medicines 172 181 4876 4885 O
specifically 182 194 4886 4898 O
targeting 195 204 4899 4908 O
T 205 206 4909 4910 O
cells 207 212 4911 4916 O

Subjects 0 8 4917 4925 O
with 9 13 4926 4930 O
a 14 15 4931 4932 O
condition 16 25 4933 4942 O
requiring 26 35 4943 4952 O
systemic 36 44 4953 4961 B-treatment
treatment 45 54 4962 4971 I-treatment
with 55 59 4972 4976 O
either 60 66 4977 4983 O
corticosteroids 67 82 4984 4999 B-treatment
( 83 84 5000 5001 O
> 84 85 5001 5002 O
10 86 88 5003 5005 B-lower_bound
mg 89 91 5006 5008 I-lower_bound
daily 92 97 5009 5014 O
prednisone 98 108 5015 5025 B-treatment
equivalent 109 119 5026 5036 O
) 119 120 5036 5037 O
or 121 123 5038 5040 O
other 124 129 5041 5046 O
immunosuppressive 130 147 5047 5064 B-treatment
medications 148 159 5065 5076 I-treatment
within 160 166 5077 5083 O
14 167 169 5084 5086 B-upper_bound
days 170 174 5087 5091 I-upper_bound
of 175 177 5092 5094 O
first 178 183 5095 5100 O
dose 184 188 5101 5105 O
of 189 191 5106 5108 O
study 192 197 5109 5114 B-treatment
drug 198 202 5115 5119 I-treatment

Subjects 0 8 5120 5128 O
with 9 13 5129 5133 O
active 14 20 5134 5140 O
autoimmune 21 31 5141 5151 B-chronic_disease
disease 32 39 5152 5159 I-chronic_disease
, 39 40 5159 5160 O
symptoms 41 49 5161 5169 O
or 50 52 5170 5172 O
conditions 53 63 5173 5183 O

Subjects 0 8 5184 5192 O
with 9 13 5193 5197 O
disease 14 21 5198 5205 O
recurrence 22 32 5206 5216 O
within 33 39 5217 5223 O
1 40 41 5224 5225 B-upper_bound
year 42 46 5226 5230 I-upper_bound
of 47 49 5231 5233 O
a 50 51 5234 5235 O
platinum 52 60 5236 5244 O
based 61 66 5245 5250 O
neoadjuvant 67 78 5251 5262 B-treatment
or 79 81 5263 5265 O
adjuvant 82 90 5266 5274 B-treatment
therapy 91 98 5275 5282 I-treatment
for 99 102 5283 5286 O
bladder 103 110 5287 5294 B-cancer
cancer 111 117 5295 5301 I-cancer

Subjects 0 8 5302 5310 O
with 9 13 5311 5315 O
histologically 14 28 5316 5330 O
confirmed 29 38 5331 5340 O
locally 39 46 5341 5348 O
advanced 47 55 5349 5357 O
/ 55 56 5357 5358 O
unresectable 56 68 5358 5370 O
or 69 71 5371 5373 O
metastatic 72 82 5374 5384 B-chronic_disease
melanoma 83 91 5385 5393 I-chronic_disease

Subjects 0 8 5394 5402 O
with 9 13 5403 5407 O
histologically 14 28 5408 5422 O
or 29 31 5423 5425 O
cytologically 32 45 5426 5439 O
confirmed 46 55 5440 5449 O
locally 56 63 5450 5457 O
advanced 64 72 5458 5466 O
/ 72 73 5466 5467 O
unresectable 73 85 5467 5479 O
or 86 88 5480 5482 O
metastatic 89 99 5483 5493 B-cancer
urothelial 100 110 5494 5504 I-cancer
carcinoma 111 120 5505 5514 I-cancer
( 121 122 5515 5516 O
including 122 131 5516 5525 O
mixed 132 137 5526 5531 O
histologies 138 149 5532 5543 O
of 150 152 5544 5546 O
urothelial 153 163 5547 5557 O
carcinoma 164 173 5558 5567 O
with 174 178 5568 5572 O
elements 179 187 5573 5581 O
of 188 190 5582 5584 O
other 191 196 5585 5590 O
subtypes 197 205 5591 5599 O
) 205 206 5599 5600 O
of 207 209 5601 5603 O
the 210 213 5604 5607 O
renal 214 219 5608 5613 O
pelvis 220 226 5614 5620 O
, 226 227 5620 5621 O
ureter 228 234 5622 5628 O
, 234 235 5628 5629 O
bladder 236 243 5630 5637 O
or 244 246 5638 5640 O
urethra 247 254 5641 5648 O
( 255 256 5649 5650 O
referred 256 264 5650 5658 O
to 265 267 5659 5661 O
broadly 268 275 5662 5669 O
in 276 278 5670 5672 O
this 279 283 5673 5677 O
protocol 284 292 5678 5686 O
as 293 295 5687 5689 O
bladder 296 303 5690 5697 B-cancer
cancer 304 310 5698 5704 I-cancer
) 310 311 5704 5705 O

Subjects 0 8 5706 5714 O
with 9 13 5715 5719 O
toxicities 14 24 5720 5730 O
attributed 25 35 5731 5741 O
to 36 38 5742 5744 O
prior 39 44 5745 5750 B-treatment
anti 45 49 5751 5755 I-treatment
- 49 50 5755 5756 I-treatment
cancer 50 56 5756 5762 I-treatment
therapy 57 64 5763 5770 I-treatment
and 65 68 5771 5774 O
which 69 74 5775 5780 O
are 75 78 5781 5784 O
not 79 82 5785 5788 O
expected 83 91 5789 5797 O
to 92 94 5798 5800 O
resolve 95 102 5801 5808 O
and 103 106 5809 5812 O
result 107 113 5813 5819 O
in 114 116 5820 5822 O
long 117 121 5823 5827 O
lasting 122 129 5828 5835 O
sequelae 130 138 5836 5844 O
such 139 143 5845 5849 O
as 144 146 5850 5852 O
neuropathy 147 157 5853 5863 B-chronic_disease
after 158 163 5864 5869 O
platinum 164 172 5870 5878 O
- 172 173 5878 5879 O
based 173 178 5879 5884 O
therapy 179 186 5885 5892 O

Subjects 0 8 5893 5901 O
with 9 13 5902 5906 O
vitiligo 14 22 5907 5915 B-chronic_disease
, 22 23 5915 5916 O
type 24 28 5917 5921 B-chronic_disease
I 29 30 5922 5923 I-chronic_disease
diabetes 31 39 5924 5932 I-chronic_disease
, 39 40 5932 5933 O
residual 41 49 5934 5942 O
hypothyroidism 50 64 5943 5957 B-chronic_disease
due 65 68 5958 5961 O
to 69 71 5962 5964 O
autoimmune 72 82 5965 5975 B-chronic_disease
thyroiditis 83 94 5976 5987 I-chronic_disease
only 95 99 5988 5992 O
requiring 100 109 5993 6002 O
hormone 110 117 6003 6010 B-treatment
replacement 118 129 6011 6022 I-treatment
, 129 130 6022 6023 O
asymptomatic 131 143 6024 6036 O
laboratory 144 154 6037 6047 O
evidence 155 163 6048 6056 O
of 164 166 6057 6059 O
autoimmune 167 177 6060 6070 B-chronic_disease
disease 178 185 6071 6078 I-chronic_disease
( 186 187 6079 6080 O
e.g. 187 191 6080 6084 O
: 191 192 6084 6085 O
+ 193 194 6086 6087 O
ANA 194 197 6087 6090 O
, 197 198 6090 6091 O
+ 199 200 6092 6093 O
RF 200 202 6093 6095 O
, 202 203 6095 6096 O
antithyroglobulin 204 221 6097 6114 O
antibodies 222 232 6115 6125 O
) 232 233 6125 6126 O
, 233 234 6126 6127 O
or 235 237 6128 6130 O
conditions 238 248 6131 6141 O
not 249 252 6142 6145 O
expected 253 261 6146 6154 O
to 262 264 6155 6157 O
recur 265 270 6158 6163 O
in 271 273 6164 6166 O
the 274 277 6167 6170 O
absence 278 285 6171 6178 O
of 286 288 6179 6181 O
an 289 291 6182 6184 O
external 292 300 6185 6193 O
trigger 301 308 6194 6201 O

The 0 3 6202 6205 O
biopsy 4 10 6206 6212 B-treatment
site 11 15 6213 6217 O
must 16 20 6218 6222 O
, 20 21 6222 6223 O
in 22 24 6224 6226 O
the 25 28 6227 6230 O
opinion 29 36 6231 6238 O
of 37 39 6239 6241 O
the 40 43 6242 6245 O
investigator 44 56 6246 6258 O
, 56 57 6258 6259 O
be 58 60 6260 6262 O
likely 61 67 6263 6269 O
to 68 70 6270 6272 O
yield 71 76 6273 6278 O
acceptable 77 87 6279 6289 O
tumor 88 93 6290 6295 B-cancer
sample 94 100 6296 6302 O
for 101 104 6303 6306 O
core 105 109 6307 6311 B-treatment
biopsies 110 118 6312 6320 I-treatment
as 119 121 6321 6323 O
described 122 131 6324 6333 O
in 132 134 6334 6336 O
Appendix 135 143 6337 6345 O
4 144 145 6346 6347 O

The 0 3 6348 6351 O
lesion 4 10 6352 6358 O
being 11 16 6359 6364 O
considered 17 27 6365 6375 O
for 28 31 6376 6379 O
palliative 32 42 6380 6390 B-treatment
radiation 43 52 6391 6400 I-treatment
is 53 55 6401 6403 O
not 56 59 6404 6407 O
a 60 61 6408 6409 O
target 62 68 6410 6416 O
lesion 69 75 6417 6423 O

The 0 3 6424 6427 O
subject 4 11 6428 6435 O
actively 12 20 6436 6444 O
refuses 21 28 6445 6452 O
chemotherapy 29 41 6453 6465 B-treatment
for 42 45 6466 6469 O
the 46 49 6470 6473 O
treatment 50 59 6474 6483 B-treatment
of 60 62 6484 6486 O
metastatic 63 73 6487 6497 B-cancer
or 74 76 6498 6500 O
locally 77 84 6501 6508 O
advanced 85 93 6509 6517 O
disease 94 101 6518 6525 O
considered 102 112 6526 6536 O
as 113 115 6537 6539 O
standard 116 124 6540 6548 O
treatment 125 134 6549 6558 O
for 135 138 6559 6562 O
this 139 143 6563 6567 O
disease 144 151 6568 6575 O
stage 152 157 6576 6581 O
( 158 159 6582 6583 O
i.e. 159 163 6583 6587 O
a 164 165 6588 6589 O
patient 166 173 6590 6597 O
who 174 177 6598 6601 O
has 178 181 6602 6605 O
relapsed 182 190 6606 6614 O
> 191 192 6615 6616 O
1 192 193 6616 6617 B-lower_bound
year 194 198 6618 6622 I-lower_bound
after 199 204 6623 6628 I-lower_bound
treatment 205 214 6629 6638 O
with 215 219 6639 6643 O
neoadjuvant 220 231 6644 6655 B-treatment
or 232 234 6656 6658 O
adjuvant 235 243 6659 6667 B-treatment
chemotherapy 244 256 6668 6680 I-treatment
) 256 257 6680 6681 O
, 257 258 6681 6682 O
despite 259 266 6683 6690 O
being 267 272 6691 6696 O
informed 273 281 6697 6705 O
by 282 284 6706 6708 O
the 285 288 6709 6712 O
investigator 289 301 6713 6725 O
about 302 307 6726 6731 O
the 308 311 6732 6735 O
treatment 312 321 6736 6745 O
options 322 329 6746 6753 O

White 0 5 6754 6759 B-clinical_variable
blood 6 11 6760 6765 I-clinical_variable
cells 12 17 6766 6771 I-clinical_variable
( 18 19 6772 6773 I-clinical_variable
WBCs 19 23 6773 6777 I-clinical_variable
) 23 24 6777 6778 I-clinical_variable
≥ 25 26 6779 6780 O
2000 27 31 6781 6785 B-lower_bound
/ 31 32 6785 6786 I-lower_bound
μL 32 34 6786 6788 I-lower_bound

Women 0 5 6789 6794 B-gender
of 6 8 6795 6797 O
childbearing 9 21 6798 6810 O
potential 22 31 6811 6820 O
* 32 33 6821 6822 O
( 33 34 6822 6823 O
WOCBP 34 39 6823 6828 O
) 39 40 6828 6829 O
not 41 44 6830 6833 B-contraception_consent
using 45 50 6834 6839 I-contraception_consent
a 51 52 6840 6841 I-contraception_consent
medically 53 62 6842 6851 I-contraception_consent
acceptable 63 73 6852 6862 I-contraception_consent
means 74 79 6863 6868 I-contraception_consent
of 80 82 6869 6871 I-contraception_consent
contraception 83 96 6872 6885 I-contraception_consent
throughout 97 107 6886 6896 O
the 108 111 6897 6900 O
study 112 117 6901 6906 O
treatment 118 127 6907 6916 B-treatment
and 128 131 6917 6920 O
for 132 135 6921 6924 O
at 136 138 6925 6927 O
least 139 144 6928 6933 O
23 145 147 6934 6936 B-lower_bound
weeks 148 153 6937 6942 I-lower_bound
following 154 163 6943 6952 O
the 164 167 6953 6956 O
last 168 172 6957 6961 O
dose 173 177 6962 6966 O
of 178 180 6967 6969 O
study 181 186 6970 6975 O
treatment 187 196 6976 6985 O
( 197 198 6986 6987 O
5 198 199 6987 6988 B-upper_bound
half 200 204 6989 6993 I-upper_bound
- 204 205 6993 6994 I-upper_bound
lives 205 210 6994 6999 I-upper_bound
of 211 213 7000 7002 O
study 214 219 7003 7008 B-treatment
drug 220 224 7009 7013 I-treatment
plus 225 229 7014 7018 O
30 230 232 7019 7021 O
days 233 237 7022 7026 O
duration 238 246 7027 7035 O
of 247 249 7036 7038 O
ovulatory 250 259 7039 7048 O
cycle 260 265 7049 7054 O

Women 0 5 7055 7060 B-gender
who 6 9 7061 7064 O
are 10 13 7065 7068 O
breast 14 20 7069 7075 O
feeding 21 28 7076 7083 O
or 29 31 7084 7086 O
pregnant 32 40 7087 7095 B-pregnancy
as 41 43 7096 7098 O
evidenced 44 53 7099 7108 O
by 54 56 7109 7111 O
positive 57 65 7112 7120 B-pregnancy
serum 66 71 7121 7126 I-pregnancy
pregnancy 72 81 7127 7136 I-pregnancy
test 82 86 7137 7141 O
( 87 88 7142 7143 O
minimum 88 95 7143 7150 O
sensitivity 96 107 7151 7162 B-clinical_variable
25 108 110 7163 7165 B-lower_bound
IU 111 113 7166 7168 I-lower_bound
/ 113 114 7168 7169 I-lower_bound
L 114 115 7169 7170 I-lower_bound
or 116 118 7171 7173 O
equivalent 119 129 7174 7184 O
units 130 135 7185 7190 O
of 136 138 7191 7193 O
HCG 139 142 7194 7197 O
) 142 143 7197 7198 O
done 144 148 7199 7203 O
within 149 155 7204 7210 O
14 156 158 7211 7213 B-upper_bound
days 159 163 7214 7218 I-upper_bound
of 164 166 7219 7221 O
first 167 172 7222 7227 O
dosing 173 179 7228 7234 O
and 180 183 7235 7238 O
urine 184 189 7239 7244 O
test 190 194 7245 7249 O
within 195 201 7250 7256 O
72 202 204 7257 7259 B-upper_bound
hours 205 210 7260 7265 I-upper_bound
of 211 213 7266 7268 O
first 214 219 7269 7274 O
dosing 220 226 7275 7281 O

subjects 0 8 7282 7290 O
with 9 13 7291 7295 O
Gilbert 14 21 7296 7303 B-chronic_disease
's 21 23 7303 7305 I-chronic_disease
syndrome 24 32 7306 7314 I-chronic_disease
who 33 36 7315 7318 O
must 37 41 7319 7323 O
have 42 46 7324 7328 O
total 47 52 7329 7334 B-clinical_variable
bilirubin 53 62 7335 7344 I-clinical_variable
≤ 63 64 7345 7346 O
3.0mg 65 70 7347 7352 B-upper_bound
/ 70 71 7352 7353 I-upper_bound
dL 71 73 7353 7355 I-upper_bound

